While Novavax's vaccine did finally reach the market in mid-2022, targeting the booster market ... development of a combination COVID-flu vaccine, and royalties. Sanofi is licensing the technology ...

Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...

Sanofi and GlaxoSmithKline have begun clinical trials of their coronavirus vaccine ... Meanwhile GSK is producing the booster that reduces the amount of active ingredient necessary to produce ...

Sanofi and Translate Bio have started ... but could be used in annual booster campaigns against emerging variants once COVID-19 becomes an endemic disease, and as an option for vaccination low ...

First thing I want to say is, you definitely should get the first booster. And that's for everyone 12 and older six months after completing their COVID-19 vaccine primary series. Now, more than ...

French officials say it's 'unacceptable' for U.S. to be prioritized if Sanofi develops COVID-19 vaccine. Jim Cramer has some thoughts on the company. French drugmaker Sanofi is rushing to develop ...

Companies are working on coronavirus booster shots, as some early studies suggest antibody levels against Covid-19 wane with time, making boosters more necessary. We explore what that means for ...

Now that over 18s can book their Covid-19 booster vaccinations, here’s everything you need to know about what to expect after your third dose. The government is continuing to urge the public to ...

More than 9.7 million people in England received a top-up vaccination during the most recent autumn booster campaign. Many pharmacies also sell the Covid jab privately. The autumn booster campaign ...